Impact of Statin Therapy on Adaptations to Aerobic Exercise



Status:Recruiting
Conditions:Peripheral Vascular Disease
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:35 - 65
Updated:3/13/2019
Start Date:February 1, 2018
End Date:July 1, 2022
Contact:Clara Amat, MS
Email:camatfernandez@kumc.edu
Phone:913-945-8834

Use our guide to learn which trials are right for you!

The purpose of this study is to determine how different doses of a statin affect muscle
health and exercise.

High cholesterol and cardiovascular disease (CVD) is currently prevented and treated with
statin therapy. Statin use can cause muscle weakness, fatigue and/or pain, and these symptoms
can increase with dose and duration of statin use. Statins may also change the ability to
exercise.

This study is testing how different doses of a statin, Lipitor, affect muscle health and
exercise. The doses that will be used in this study (20 mg/day or 80 mg/day) are typical for
treating high cholesterol.

This study is expected to last about 14 weeks.

Inclusion Criteria:

- Body Mass Index (BMI) between 25-43 kg^m2

- Sedentary (less than 30 min of physical activity/week during last 6 months and less
than 7,500 steps/day measures by pedometer at baseline)

- Weight stable (no more than 5% change in body weight the previous 3 months)

- >5% risk for a cardiovascular event in the next 10 years according to the 2013
American College of Cardiology/American Heart Association risk calculator

- Stable doses of medications for 90 days

- Willing to stop all Nonsteroidal Antiinflammatory Drugs (NSAIDs) and aspirin for 7
days prior to muscle biopsy

Exclusion Criteria:

- Smoking

- Use of statins in the last 6 months

- Use of other medications or supplements that affect lipid profiles or body weight in
the last 6 months (e.g., fibric acids, bile acid sequestrants, nicotinic acids, fish
oil)

- Diagnosis of chronic diseases including cardiovascular (CVD), diabetes, other
metabolic diseases (e.g., thyroid), cancer, HIV, or acquired immunodeficiency syndrome

- History of abnormal bleeding problems

- Currently taking (within the last 10 days) anti-platelet medication (Plavix),
Warfarin, and other anti-coagulants (eliquis, pradaxa, and xarelto) medications

- >2 fold upper normal limit (UNL) for alanine aminotransferase (ALT) or creatinine

- Women who are pregnant or breastfeeding

- Individuals with polymorphisms known to be associated with susceptibility for statin
induced myopathies (tested at screening)

- Currently enrolled in another research study
We found this trial at
1
site
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials